NWRN — Newron Pharmaceuticals SpA Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣135.64m
- CH₣170.69m
- €9.06m
Annual cashflow statement for Newron Pharmaceuticals SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.2 | -19.6 | -14.9 | -17.5 | -16.2 |
| Depreciation | |||||
| Non-Cash Items | -2.79 | 0.619 | 4.29 | 5.48 | 5.51 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.771 | 3.19 | -1.06 | 0.702 | 0.351 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -22 | -15.6 | -11.4 | -11.1 | -10.1 |
| Capital Expenditures | -0.051 | -0.035 | -0.02 | -0.018 | -0.011 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.881 | -0.581 | 8.44 | -0.299 | 3.26 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.932 | -0.616 | 8.42 | -0.317 | 3.25 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17.3 | 7.37 | 14.8 | -0.186 | -0.192 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.57 | -8.84 | 11.8 | -11.6 | -7.09 |